Update: April 10, 2026
The FDA has updated its Electronic Medical Device Reporting (eMDR) framework, confirming the transition to the ESG NextGen Unified Submission Portal
As of April 14, 2025, the ESG NextGen portal replaces the legacy WebTrader interface, providing a web-based platform to submit regulatory information and track submission status

